18 May 2013
Keywords: pegasys, get, fast-track, review, usa, roche, pegylated
Article | 05 July 2000
Roche's Pegasys (pegylated interferon alfa) looks set to be granted afast-track regulatory review in the USA, according to analyst Ian
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 July 2000
17 May 2013
© 2013 thepharmaletter.com